Claims
- 1. A pet milk powder comprising a cow's milk powder which contains lactose, and a lactase in an amount sufficient to reduce symptoms of gastrointestinal intolerance resulting from ingestion of the cow's milk powder.
- 2. A pet milk powder according to claim 1 in which the lactase is one that has optimum activity under acidic conditions.
- 3. A pet milk powder according to claim 1 in which the lactase is a β-galactosidase.
- 4. A pet milk powder according to claim 3 in which the β-galactosidase is of microbial origin.
- 5. A pet milk powder according to claim 1 in which the lactase is present in an amount of between 0.05 to 0.4% by weight of the powder.
- 6. A pet milk powder according to claim 1 in which the lactase provides about 75 UI/100 g to about 125 UI/100 g of powder.
- 7. A pet milk powder according to claim 1 which further comprises at least one of a lipid source, a protein source, one or more vitamins or one or more minerals.
- 8. A pet milk powder according to claim 1 which further comprises a calcium source.
- 9. A pet milk powder according to claim 1 and specifically formulated for cats, the powder containing taurine and choline.
- 10. A pet milk powder according to claim 1 and specifically formulated for dogs, the powder containing choline.
- 11. A method for reducing the symptoms of gastrointestinal intolerance in pets who ingest a reconstituted pet milk powder comprising a cow's milk powder containing lactose, which method comprises administering to the pet a lactase in an amount sufficient to reduce symptoms of gastrointestinal intolerance in the pet.
- 12. The method according to claim 11 in which the lactase is present in the pet milk powder in an amount of between about 0.05 to 0.4% by weight of the powder.
- 13. The method according to claim 11 in which the lactase is one that has optimum activity under acidic conditions.
- 14. The method according to claim 11 in which the lactase is a β-galactosidase.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of the U.S. national phase designation of International application PCT/EP99/06621, filed Sep. 7, 1999, the content of which is expressly incorporated herein by reference thereto.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60099383 |
Sep 1998 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/EP99/06621 |
Sep 1999 |
US |
Child |
09801264 |
Mar 2001 |
US |